Captopril: a free radical scavenger.
Open Access
- 1 March 1989
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 27 (3) , 396-399
- https://doi.org/10.1111/j.1365-2125.1989.tb05384.x
Abstract
The use of captopril in heart failure and hypertension is becoming increasingly accepted. Captopril has a sulphydryl group in its molecular structure. We wondered if this might confer free radical scavenging activity on the drug and have investigated this in an in vitro system. Results show that captopril is a free radical scavenger and we suggest that this action might be relevant in its use in heart failure and other vascular diseases.This publication has 11 references indexed in Scilit:
- New Drugs: Angiotensin converting enzyme inhibitorsBMJ, 1988
- A Comparison of the Free Radical Scavenging Activity of Leukotrienes and ProstaglandinsFree Radical Research Communications, 1988
- Increased Diene Conjugates in Diabetic Subjects with MicroangiopathyDiabetic Medicine, 1987
- Antioxidant drugs and shock therapy.1987
- SUPEROXIDE ANION PRODUCTION BY ADRIAMYCINOL FROM CARDIAC SARCOSOMES AND BY MITOCHONDRIAL NADH DEHYDROGENASE1986
- Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.BMJ, 1986
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985
- Heparin inhibition of polymorphonuclear leukocyte activation in vitro. A possible pharmacological approach to granulocyte-mediated vascular damageThrombosis Research, 1984
- A relationship between thiols and the superoxide ionFEBS Letters, 1981
- Superoxide Dismutase (Erythrocuprein) and Free Radicals in Clinical ChemistryAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1976